Metabolic dysfunction-associated steatotic liver disease (MASLD) was recently proposed as an alternative disease concept to nonalcoholic fatty liver disease (NAFLD). We aimed to investigate the prognosis in patients with biopsy-confirmed MASLD using data from a multicenter study.

中文翻译：

---

活检证实的 MASLD 的预后：CLIONE 研究的子分析。

代谢功能障碍相关的脂肪肝病（MASLD）最近被提出作为非酒精性脂肪肝病（NAFLD）的替代疾病概念。我们的目的是利用多中心研究的数据来调查活检确诊的 MASLD 患者的预后。